In Precision Oncology, With Innovation Comes Challenge

Comments
In Precision Oncology, With Innovation Comes Challenge

Cancer therapies dominate 40% of the global clinical pipeline, and the field of oncology is leading the precision medicine revolution. As this field continues to mature and evolve, it will require increasingly sophisticated technologies to deal with the dichotomy facing precision oncology drug developers: patient scarcity, clinical complexity and data abundance.

Download our new oncology infographic (there's just a snippet above) and learn how we're making it easier for patients to participate in clinical studies.

About Author

Jose Belloso

Product Marketing Manager